Timothy Chiang
Stock Analyst at Capital One
(1.19)
# 3,688
Out of 4,984 analysts
5
Total ratings
20%
Success rate
0.97%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Timothy Chiang
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ANIP ANI Pharmaceuticals | Initiates: Overweight | n/a | $95.36 | - | 1 | Mar 15, 2024 | |
| PTGX Protagonist Therapeutics | Initiates: Buy | $55 | $59.22 | -7.13% | 2 | Feb 11, 2022 | |
| AMPH Amphastar Pharmaceuticals | Upgrades: Outperform | n/a | $26.98 | - | 1 | Oct 5, 2020 | |
| IDYA IDEAYA Biosciences | Initiates: Outperform | $28 | $24.44 | +14.57% | 1 | Sep 1, 2020 |
ANI Pharmaceuticals
Mar 15, 2024
Initiates: Overweight
Price Target: n/a
Current: $95.36
Upside: -
Protagonist Therapeutics
Feb 11, 2022
Initiates: Buy
Price Target: $55
Current: $59.22
Upside: -7.13%
Amphastar Pharmaceuticals
Oct 5, 2020
Upgrades: Outperform
Price Target: n/a
Current: $26.98
Upside: -
IDEAYA Biosciences
Sep 1, 2020
Initiates: Outperform
Price Target: $28
Current: $24.44
Upside: +14.57%